Skip to main content
. Author manuscript; available in PMC: 2021 Oct 26.
Published in final edited form as: Otol Neurotol. 2017 Feb;38(2):264–271. doi: 10.1097/MAO.0000000000001279

TABLE 1.

Demographics

n %
Patients 86
 Male 69 80.2
 Female 17 19.8
Age (yr)
 Mean (SDa) 67.1 (13.7)
 Range 20.6–89.4
Tobacco use
 History of use 54 62.8
 Negative history 32 37.2
 Pack-years
  Mean (SDa) 31.3 (22.3)
  Range 2–100
Continued use after surgery 13
Comorbidities
 Diabetes mellitus 18 20.9
 Cardiovascular disease 15 17.4
 Peripheral vascular disease 9 10.5
 Immunosuppressedb 7 8.1
a

Standard deviation.

b

Includes subjects on chronic immunosuppressive medication (e.g., chronic prednisone usage).